{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:04:22Z","timestamp":1781089462868,"version":"3.54.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study aims to explore the prognostic assessment value of bone marrow plasma cell morphology, Vitamin D (Vit D), and Interleukin-6 (IL-6) in patients with Multiple Myeloma (MM), with the potential to provide local medical care for follow-up patients and indirectly alleviate the difficulty of accessing healthcare in higher-level hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data were collected from 111 MM patients admitted to the Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, between January 2022 and December 2024. The morphological characteristics of plasma cells in different stages of the disease were analyzed in patients with poor prognosis. The correlations between the number of plasma cells, Vit D, IL-6, laboratory indicators, and disease stages were investigated. Receiver Operating Characteristic (ROC) curves were plotted based on follow-up data to assess the prognostic value of these three indicators in MM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The heterogeneity of plasma cell morphology is evident in MM patients, and there are significant differences in the number of plasma cells between the Durie-Salmon Staging System (DS) and the International Staging System (ISS) (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.05). There were marked differences in bone marrow plasma cell count, Vit D levels, and IL-6 levels across different stages (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). The number of bone marrow plasma cells and IL-6 levels before chemotherapy were significantly higher than those after chemotherapy, with statistically significant differences (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Vit D positively correlated with Serum Albumin (ALB) (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.581,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05), while IL-6 negatively correlated with Hemoglobin (HGB) (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f\u22120.556,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). The number of bone marrow plasma cells and IL-6 levels positively correlated with DS stages in MM patients (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.4466, 0.6347,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.0001, &amp;lt;0.0001, respectively). Vit D negatively correlated with DS stages in MM patients (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f\u22120.6312,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001). The combined detection AUC of 0.835 was superior to that of IL-6 (\n                      <jats:italic>z<\/jats:italic>\n                      \u202f=\u202f2.148,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.032) and Vit D (\n                      <jats:italic>z<\/jats:italic>\n                      \u202f=\u202f1.978,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.042) alone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined detection of bone marrow cellular morphology, Vit D, and IL-6 can provide effective prognostic monitoring for MM patients, potentially offering local follow-up care, reducing economic burdens, and improving quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1593130","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:41:41Z","timestamp":1750210901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma"],"prefix":"10.3389","volume":"12","author":[{"given":"Ping","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Fengdu County Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fengdu County Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fengdu County Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fengdu County Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zesong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"20705","DOI":"10.1038\/s41598-023-47906-y","article-title":"A population-based study on incidence trends of myeloma in the United States over 2000-2020","volume":"13","author":"Mousavi","year":"2023","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00330-020-07177-x","article-title":"Prognostic value of18F-fluorodeoxyglucose positron emission tomography\/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis","volume":"31","author":"Han","year":"2021","journal-title":"Eur Radiol"},{"key":"ref3","first-page":"473","article-title":"Diagnostic and prognostic value of bone marrow plasma cell morphology in patients with plasma cell myeloma","volume":"46","author":"Lyu","year":"2023","journal-title":"Chin J Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.3390\/nu15204409","article-title":"Calcifediol: mechanisms of action","volume":"15","author":"Donati","year":"2023","journal-title":"Nutrients"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.19746\/j.cnki.issn.1009-2137.2025.01.023","article-title":"Role of total Vitamin D, total procollagen type I amino-terminal propeptide and \u03b2-crosslaps in multiple myeloma","volume":"33","author":"Wang","year":"2025","journal-title":"Chin J Exp Hematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.thromres.2015.03.019","article-title":"Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro","volume":"135","author":"Gao","year":"2015","journal-title":"Thromb Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3760\/cma.j.cn112138-20220414-00278","article-title":"Interpretation of treatment of relapsed\/refractory multiple myeloma patients in the guidelines for the diagnosis and management of multiple myeloma in China(2022 revision)","volume":"61","author":"Cai","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.clml.2023.03.005","article-title":"Impact of disease progression, line of therapy, and response on health-related quality of life in multiple myeloma: a systematic literature review","volume":"23","author":"Fonseca","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/dc.22986","article-title":"Myeloma cell morphology and morphometry in correlation with clinical stages and survival","volume":"41","author":"Seili-Bekafigo","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/bjh.19890","article-title":"Dutcher bodies and Russell bodies in a case of t(11;14) multiple myeloma","volume":"206","author":"Wu","year":"2024","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/bjh.19788","article-title":"Multiple myeloma with acicular crystalline inclusion bodies","volume":"205","author":"Cai","year":"2024","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1182\/blood-2016-10-745059","article-title":"Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma","volume":"129","author":"Gupta","year":"2017","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1113\/JP274887","article-title":"Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis","volume":"595","author":"Berridge","year":"2017","journal-title":"J Physiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","article-title":"Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1","volume":"188","author":"Zhang","year":"2012","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1157969","DOI":"10.3389\/fendo.2023.1157969","article-title":"Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis","volume":"14","author":"Bao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.3390\/curroncol30030248","article-title":"Vitamin D and multiple myeloma: a scoping review","volume":"30","author":"Mirhosseini","year":"2023","journal-title":"Curr Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/gtmb.2015.0169","article-title":"Association of IL-6 promoter and receptor polymorphisms with multiple myeloma risk: a systematic review and Meta-analysis","volume":"20","author":"Li","year":"2016","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00277-020-04192-2","article-title":"Dutcher bodies in IgA multiple myeloma","volume":"99","author":"Martino","year":"2020","journal-title":"Ann Hematol"}],"updated-by":[{"DOI":"10.3389\/fmed.2026.1886789","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1593130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:09:03Z","timestamp":1781086143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1593130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":20,"alternative-id":["10.3389\/fmed.2025.1593130"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1593130","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1593130"}}